A previous study reported that curcumin exhibits antitumor activity in triple-negative breast cancer patient-derived xenograft tumor mice by inhibiting the expression of salt-inducible kinase 3 (SIK3) (Cheng et al., 2021). The gene discussed is SIK3; the disease is triple-negative breast carcinoma.